Welcome to our dedicated page for BED BATH & BEYOND SEC filings (Ticker: BBBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bed Bath & Beyond, Inc. filings document an ecommerce-focused retailer’s operating results, material agreements, acquisition activity, governance matters, and capital structure. Form 8-K reports include quarterly and annual financial-result releases, material definitive agreements, completion reports for acquisitions such as The Brand House Collective, executive appointments, compensation arrangements, and other corporate events.
Proxy and registration-related filings cover annual meeting proposals, director elections, auditor ratification, say-on-pay matters, charter amendments, equity-plan matters, shareholder voting mechanics, and disclosures tied to common stock and warrants. The filing record also addresses the company’s brand portfolio, retail execution, technology and administrative costs, risk factors, and public-company governance.
Bed Bath & Beyond, Inc. reported that on January 9, 2026 it purchased an additional participation in term loans issued by The Container Store, Inc. under an existing Term Loan Credit Agreement. The aggregate purchase price for this new participation was $2,168,266.96, following an earlier purchase on November 25, 2025 for $6,461,843.09. Through these transactions, the company will share in the rights to receive interest and principal repayments on the loans, as well as any related enforcement or remedy rights under the credit agreement.
Bed Bath & Beyond, Inc. is registering shares to acquire The Brand House Collective (TBHC) in an all‑stock merger. TBHC will merge into a Bed Bath & Beyond subsidiary and become a wholly owned subsidiary of Bed Bath & Beyond.
Each share of TBHC common stock will be converted into 0.1993 shares of Bed Bath & Beyond common stock, plus cash instead of fractional shares. Using Bed Bath & Beyond’s November 21, 2025 NYSE closing price of $5.56, this implied about $1.11 of value per TBHC share at signing, though the actual value will move with Bed Bath & Beyond’s share price.
TBHC’s board unanimously recommends shareholders vote for the merger, an advisory vote on merger‑related executive compensation, and a possible adjournment to solicit more proxies. If completed, former TBHC holders are expected to own about 4.2% of the combined company, which will continue to trade on the NYSE under “BBBY,” while TBHC will be delisted from Nasdaq. If the deal fails under specified circumstances, TBHC may owe Bed Bath & Beyond a $1.0 million termination fee and a $0.3 million expense reimbursement.
Bed Bath & Beyond, Inc. reported a leadership change at the top of the company. The Board appointed Marcus Lemonis, currently Executive Chairman and the company’s principal executive officer, as Chief Executive Officer, effective January 1, 2026. He will continue to serve as Executive Chairman and principal executive officer, consolidating the company’s senior leadership roles under one individual. The company plans to enter into an employment agreement with Mr. Lemonis, with key terms to be disclosed in a later filing.
The company also ended the employment of Alexander Thomas, its Chief Operating Officer and principal operating officer, as of the same effective date. Mr. Thomas is expected to act as an advisor for a transition period after January 1, 2026 to support an orderly handover of his responsibilities.
Bed Bath & Beyond, Inc. reported that on November 25, 2025 it purchased, via a participation agreement, a portion of loans issued by The Container Store, Inc. under a term loan credit agreement originally dated January 28, 2025 and amended on September 15, 2025. The aggregate purchase price for the company’s participation in these loans was $6,461,843.09.
Through this participation, Bed Bath & Beyond will share in the right to receive interest and principal payments on the loans, as well as in any exercise of rights or remedies related to those loans.
Bed Bath & Beyond, Inc. (BBBY) announced an all-stock merger agreement to acquire The Brand House Collective, Inc. (TBHC), with each TBHC share converting into the right to receive 0.1993 shares of BBBY common stock at closing, plus cash in lieu of fractional shares. TBHC restricted stock units and options will convert into BBBY equity based on the same exchange ratio at the merger’s effective time.
Closing depends on TBHC shareholder approval (including a disinterested shareholder vote), effectiveness of a Form S-4 registration statement, NYSE listing of the new BBBY shares, actions regarding TBHC’s Bank of America credit facility and typical regulatory and no–material-adverse-effect conditions. TBHC must pay a $1,025,300 termination fee in certain failed-deal scenarios and may reimburse $341,800 of BBBY expenses if shareholders do not approve the deal. The merger agreement may be terminated if not completed by May 24, 2026.
Separately, BBBY amended its term loan credit agreement to increase delayed draw term loan commitments to TBHC by $10,000,000, for an aggregate of $30,000,000, and the lead borrower concurrently borrowed $10,000,000 of delayed draw term loans.
Bed Bath & Beyond (BBBY) reported an equity award to a senior executive. On 11/14/2025, an officer serving as Executive Vice President, Chief Digital, Product, and Technology Officer received 116,686 restricted stock units (RSUs) of Bed Bath & Beyond common stock at a price of $0 per unit.
Each RSU represents a contingent right to receive one share of common stock. The award vests in three equal installments at the close of business on November 3, 2026, November 3, 2027 and November 3, 2028, with vested shares to be delivered to the executive promptly after each vesting date. Following this grant, the executive holds 116,686 derivative securities directly.
Bed Bath & Beyond, Inc. (BBBY) reported that one of its executives, serving as Executive Vice President, Chief Digital, Product, and Technology Officer, filed an initial ownership report on Form 3 as of 11/14/2025. The filing states that this officer currently does not beneficially own any Bed Bath & Beyond securities, and both the non-derivative and derivative ownership tables show no reported holdings.
Bed Bath & Beyond (BBBY) Chief Accounting Officer, who files individually, reported equity award activity and a warrant distribution. On 11/15/2025, the officer acquired 1,186 shares of common stock at an exercise price of $0.0001 through the vesting and settlement of restricted stock units, and disposed of 289 shares at $6.03, typically reflecting shares withheld or sold to cover taxes. Following these transactions, the officer directly holds 3,077 shares of common stock.
In the derivative table, the officer shows 26,906 restricted stock units beneficially owned after the reported RSU conversion, each representing one share of common stock, vesting in two equal installments on November 15, 2025 and November 15, 2026. The officer also acquired 218 common stock warrants with a $15.50 exercise price from an October 7, 2025 pro-rata distribution to all common shareholders, which become exercisable once an S-3 registration statement for the warrant shares is declared effective and remain exercisable through October 7, 2026.
Bed Bath & Beyond Inc.'s Chief Operating Officer reported equity transactions reflecting routine compensation activity. On 11/15/2025, 1,186 shares of common stock were acquired upon the vesting and settlement of restricted stock units at an exercise price of $0.0001 per share, and 343 shares were disposed of at $6.03 per share, typically consistent with tax withholding. Following these transactions, the reporting person directly owned 8,793 common shares and indirectly held 66 shares through a 401(k) plan balance as of 11/17/2025.
In the derivative table, 1,186 restricted stock units converted into common stock, leaving 43,143 derivative securities reported as beneficially owned. The filing also lists 794 common stock warrants with an exercise price of $15.50 per share, originally issued on 10/07/2025 as a pro-rata distribution. These warrants will become exercisable once a Form S-3 registering the underlying shares is declared effective by the SEC and may be exercised through 10/07/2026.
Bed Bath & Beyond Inc. (BBBY): A series of the Amplify ETF Trust filed a Schedule 13G reporting beneficial ownership of 4,496,275 shares of BBBY common stock, representing 6.53% of the class as of 09/30/2025.
The filer reports sole voting power over 4,496,275 shares and sole dispositive power over 4,496,275 shares, with no shared voting or dispositive power. The filing identifies the filer as an investment company registered under section 8 of the Investment Company Act of 1940.
The filing notes the fund’s clients have the right to receive or direct the receipt of dividends or sale proceeds from the reported securities, and that no one other person’s interest exceeds 5%.